The poor functionality of AFP (sensitivity for early HCC, 39% to 64%; specificity, 76% to 97%) and its ineffectiveness in accurately detecting early HCC has led to further research into identifying better biomarkers for early diagnosis during surveillance [49]. The gene discussed is AFP; the disease is hepatocellular carcinoma.